An Innovative Canadian Pharmaceutical Company

Revenue Projected at $160,000,000 by 2025

Sponsored
Message: AGORACOM Small Cap 60: Valeo Pharma Says Physician Response Has Been Very Favourable To Company’s Asthma Drugs

AGORACOM Small Cap 60: Valeo Pharma Says Physician Response Has Been Very Favourable To Company’s Asthma Drugs

posted on Nov 25, 2021 01:42PM

Share
New Message
Please login to post a reply